Cargando…

Zoledronic acid increases docetaxel cytotoxicity through pMEK and Mcl-1 inhibition in a hormone-sensitive prostate carcinoma cell line

BACKGROUND: In prostate cancer, the identification of drug combinations that could reduce the tumor cell population and rapidly eradicate hormone-resistant cells potentially present would be a remarkable breakthrough in the treatment of this disease. METHODS: The study was performed on a hormone-sen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fabbri, Francesco, Brigliadori, Giovanni, Carloni, Silvia, Ulivi, Paola, Vannini, Ivan, Tesei, Anna, Silvestrini, Rosella, Amadori, Dino, Zoli, Wainer
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2525627/ https://www.ncbi.nlm.nih.gov/pubmed/18691406 http://dx.doi.org/10.1186/1479-5876-6-43

Ejemplares similares

Inhibition of breast cancer cell proliferation in repeated and non-repeated treatment with zoledronic acid
por: Ibrahim, Toni, et al.
Publicado: (2012)

Low-dose taxotere enhances the ability of sorafenib to induce apoptosis in gastric cancer models
por: Tesei, Anna, et al.
Publicado: (2011)

Short Interfering RNA Directed against the SLUG Gene Increases Cell Death Induction in Human Melanoma Cell Lines Exposed to Cisplatin and Fotemustine
por: Vannini, Ivan, et al.
Publicado: (2007)

Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines
por: Tesei, Anna, et al.
Publicado: (2007)

Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines
por: Zoli, Wainer, et al.
Publicado: (2005)

Peripheral Blood miR-328 Expression as a Potential Biomarker for the Early Diagnosis of NSCLC
por: Ulivi, Paola, et al.
Publicado: (2013)

In vitro and in vivo evaluation of NCX 4040 cytotoxic activity in human colon cancer cell lines
por: Tesei, Anna, et al.
Publicado: (2005)

Sequential events of apoptosis involving docetaxel, a microtubule-interfering agent: A cytometric study
por: Fabbri, Francesco, et al.
Publicado: (2006)

Peritoneal carcinomatosis from ovarian cancer: chemosensitivity test and tissue markers as predictors of response to chemotherapy
por: Arienti, Chiara, et al.
Publicado: (2011)

Multiple Marker Detection in Peripheral Blood for NSCLC Diagnosis
por: Ulivi, Paola, et al.
Publicado: (2013)

Subcellular localisation of pMEK has a different prognosis in locally advanced head and neck cancer treated with concomitant radiochemotherapy
por: Gomez-Millan, J., et al.
Publicado: (2016)

Urine Cell-Free DNA Integrity as a Marker for Early Prostate Cancer Diagnosis: A Pilot Study
por: Casadio, Valentina, et al.
Publicado: (2013)

Discrepancies between VEGF −1154 G>A Polymorphism Analysis Performed in Peripheral Blood Samples and FFPE Tissue
por: Marisi, Giorgia, et al.
Publicado: (2014)

Detection of KRAS mutant alleles in circulating cell-free tumor DNA in colorectal cancer patients resistant to cetuximab
por: Del Re, Marzia, et al.
Publicado: (2014)

RANK/RANK-L/OPG in Patients with Bone Metastases Treated with Anticancer Agents and Zoledronic Acid: A Prospective Study
por: Mercatali, Laura, et al.
Publicado: (2013)

Predictive Role of Telomerase Activity in the Clinical Outcome of Patients with Benign Lesions of the Uterine Cervix or CIN
por: Bravaccini, Sara, et al.
Publicado: (2012)

DNA Methylation profiles as predictors of recurrence in non muscle invasive bladder cancer: an MS-MLPA approach
por: Casadio, Valentina, et al.
Publicado: (2013)

Docetaxel and gemcitabine activity in NSCLC cell lines and in primary cultures from human lung cancer
por: Zoli, W, et al.
Publicado: (1999)

EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximab
por: CHIADINI, ELISA, et al.
Publicado: (2015)

miRNAs as Non-Invasive Biomarkers for Lung Cancer Diagnosis
por: Ulivi, Paola, et al.
Publicado: (2014)

The current role of telomerase in the diagnosis of bladder cancer
por: Bravaccini, Sara, et al.
Publicado: (2009)

Docetaxel/zoledronic acid: Multisystem toxicities: case report
Publicado: (2020)

Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer
por: Passardi, Alessandro, et al.
Publicado: (2008)

MEK and MCL-1 sequential inhibition synergize to enhance rhabdomyosarcoma treatment
por: Alcon, Clara, et al.
Publicado: (2022)

KRAS, BRAF and PIK3CA Status in Squamous Cell Anal Carcinoma (SCAC)
por: Casadei Gardini, Andrea, et al.
Publicado: (2014)

eNOS polymorphisms as predictors of efficacy of bevacizumab-based chemotherapy in metastatic colorectal cancer: data from a randomized clinical trial
por: Ulivi, Paola, et al.
Publicado: (2015)

In vitro irradiation system for radiobiological experiments
por: Tesei, Anna, et al.
Publicado: (2013)

Effect of Small Molecules Modulating Androgen Receptor (SARMs) in Human Prostate Cancer Models
por: Tesei, Anna, et al.
Publicado: (2013)

MicroRNA-16 Restores Sensitivity to Tyrosine Kinase Inhibitors and Outperforms MEK Inhibitors in KRAS-Mutated Non-Small Cell Lung Cancer
por: Fanini, Francesca, et al.
Publicado: (2021)

Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment
por: Brubaker, Kristen D, et al.
Publicado: (2006)

First evidence of a large CHEK2 duplication involved in cancer predisposition in an Italian family with hereditary breast cancer
por: Tedaldi, Gianluca, et al.
Publicado: (2014)

Rationale for a Combination Therapy Consisting of MCL1- and MEK-Inhibitors in Acute Myeloid Leukemia
por: Seipel, Katja, et al.
Publicado: (2019)

Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: A single center study
por: Ulivi, Paola, et al.
Publicado: (2012)

Quantitative Fluorescence Determination of Long-Fragment DNA in Stool as a Marker for the Early Detection of Colorectal Cancer
por: Calistri, Daniele, et al.
Publicado: (2009)

A Comparison of Hepatocyte Cytotoxic Mechanisms for Docetaxel and PLGA-Docetaxel Nanoparticls
por: Daraei, Bahram, et al.
Publicado: (2017)

Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience
por: Passardi, Alessandro, et al.
Publicado: (2006)

Purported Mcl-1 inhibitor marinopyrrole A fails to show selective cytotoxicity for Mcl-1-dependent cell lines
por: Eichhorn, J M, et al.
Publicado: (2013)

IL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia
por: Musuraca, Gerardo, et al.
Publicado: (2015)

Enhancement of docetaxel-induced cytotoxicity and apoptosis by all-trans retinoic acid (ATRA) through downregulation of survivin (BIRC5), MCL-1 and LTbeta-R in hormone- and drug resistant prostate cancer cell line, DU-145
por: Kucukzeybek, Yuksel, et al.
Publicado: (2008)

Phase II study of zoledronic acid combined with docetaxel for non-small-cell lung cancer: West Japan Oncology Group
por: Murakami, Haruyasu, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_03imlsunl4qaketc94jhfr67pp